What is Lucent Pathology Partners?
Lucent Pathology Partners is a prominent provider of advanced anatomical and clinical laboratory services operating across Northern California. The company specializes in a comprehensive suite of pathology areas, including breast, gastrointestinal, liver, dermatopathology, cytopathology, gynecologic, hematopathology, genitourinary, pulmonary, and oral pathology. Enhancing its service offerings, Lucent Pathology Partners also provides digital pathology solutions and second opinion consultations, aiming to optimize client workflows and deliver independent, expert case analysis. Their team of seasoned pathologists is committed to delivering precise, timely, and individualized patient care.
How much funding has Lucent Pathology Partners raised?
Lucent Pathology Partners has raised a total of $654K across 2 funding rounds:
Debt
$350K
Debt
$304K
Debt (2020): $350K with participation from PPP
Debt (2021): $304K led by PPP
Key Investors in Lucent Pathology Partners
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Lucent Pathology Partners?
The recent major strategic investment signals a pivotal moment for Lucent Pathology Partners, likely indicating a phase of accelerated scaling and market expansion. This capital infusion is expected to fuel advancements in their digital pathology capabilities and potentially broaden their service reach. The company's focus on specialized pathology areas and second opinions positions it for continued leadership and innovation in diagnostic services, suggesting a strategic push to solidify its enterprise-level market position.
See full Lucent Pathology Partners company page
